Fractional flow reserve (FFR)

Incorporating Coronary CTA and HeartFlow Into the Clinical Workflow

01/07/2019

We embraced HeartFlow technology for two reasons: one is its accuracy as a go-to diagnostic test, but the other is the power it holds in helping to plan interventions for patients before getting to the cath lab.

We embraced HeartFlow technology...

01/07/2019

Cath Lab Digest

Clinical Editor's Corner

Return of IC Adenosine for FFR: History, Dose and Technique

12/04/2015

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Several thought leaders in coronary physiology recommend returning to intracoronary (IC) adenosine. I thought it might be worthwhile to discuss how IC adenosine came to be used, its best dosing, and a couple tips on technique for...

Several thought leaders in...

12/04/2015

Cath Lab Digest

Technology Pulse

The Use of iFR Measurements to Simplify Decision Making for PCI

04/30/2015

Vincent J. Pompili , MD, FACC, FSCAI;

iFR assesses whether a stenosis is causing a limitation of blood flow in coronary arteries with subsequent ischemia without the requirement of running adenosine.

iFR assesses whether a stenosis...

04/30/2015

Cath Lab Digest

Limitations of FFR (or any Physiologic Measurement) During STEMI: Implications for FFR-Guided Revascularization in the ACS Patient

04/03/2015

Morton J. Kern , MD, MSCAI, FACC, FAHA;

A 48-year-old man comes to the emergency room with 2 hours of chest pain and electrocardiogram (ECG) showing inferior ST elevation (Figure 1)..

A 48-year-old man comes to the...

04/03/2015

Cath Lab Digest

Clinical and Economic Advantages of the iFR Modality for Physiologic Assessment

12/05/2014

Bruce A. Samuels , MD;

Approved by the FDA in March 2014, iFR is a diagnostic tool used to assess whether a stenosis is causing a limitation of blood flow in coronary arteries with subsequent ischemia. This tool preserves the advantages of physiology-based...

Approved by the FDA in March...

12/05/2014

Cath Lab Digest